ReviewJournal of medical case reports2026
Metachronous solitary metastasis from left testicle seminoma presenting as a large intracranial tumor 4 years post-treatment: a case report and review of the literature.
Review in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeminoma is a highly curable testicular tumor, but metastatic spread to the central nervous system (CNS) is uncommon, and isolated CNS relapse is exceptionally rare. In this article, we describe a rare case of isolated CNS relapse presenting as a large brain tumor four years after completion of therapy for testicular stage IIB seminoma. CASE PRESENTATION: A 34‑year‑old Syrian male with a history of successfully treated left testicular seminoma four years earlier presented to the Neurology Department with headaches, vomiting, and right‑hand weakness. Brain magnetic resonance imaging (MRI) revealed an intra‑axial mass initially suspected to be a glioma based on imaging characteristics. However, after surgical resection, histopathological examination and immunohistochemical analysis confirmed the lesion to be a metachronous seminoma metastasis to the brain (refer to Graphical Abstract).
conclusionThis report highlights the importance of considering metachronous seminoma metastasis to the brain in the differential diagnosis when neurological symptoms suggest an intracranial lesion, even for an extended period after completion of treatment for the primary tumor, despite the rarity of such metastases. Current surveillance guidelines for stage II seminoma do not include routine brain imaging. This case underscores the need for a high index of clinical suspicion and a low threshold for brain imaging in symptomatic patients, even years after treatment. Future research should identify risk factors for CNS relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.